Trends in the use of psychotropic drugs in Taiwan: A population-based national health insurance study, 1997-2004

Psychiatric Services

Volumn 58, Issue 4, 2007, Pages 554-557

  Chien, I Chia ^a,b   Bih, Shin Huey ^c   Chou, Yiing Jenq ^d   Lin, Ching Heng ^d   Lee, Wen Guang ^e   Chou, Pesus ^d  

^a Jianan Mental Hospital   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c Department of Occupational Therapy   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e Jianan Mental Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; HYPNOTIC AGENT; LAMOTRIGINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZIPRASIDONE;

AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG USE; FOLLOW UP; HEALTH SERVICE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; NATIONAL HEALTH INSURANCE; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PREVALENCE; RANDOM SAMPLE; TAIWAN;

EID: 34247325209     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2007.58.4.554     Document Type: Article

References (15)

1. Alonso J, Angermeyer MC, Bernert S, et al: Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ES-EMeD) project. Acta Psychiatrica Scandinavica: Supplementum 109:55-64, 2004
2. Ohayon MM, Lader MH: Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. Journal of Clinical Psychiatry 63:817-825, 2002
3. Paulose-Ram R, Jonas BS, Orwig D, et al: Prescription psychotropic medication use among the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994. Journal of Clinical Epidemiology 57:309-317, 2004
4. Aparasu RR, Bhatara V, Gupta S: US national trends in the use of antipsychotics during office visits, 1998-2002. Annals of Clinical Psychiatry 17:147-152, 2005
5. Mamdani M, Rapoport M, Shulman KI, et al: Mental health-related drug utilization among older adults. American Journal of Geriatric Psychiatry 13:892-900, 2005
6. Ananth J, Parameswaran S, Gunatilake S: Side effects of atypical antipsychotic drugs. Current Pharmaceutical Design 10:2219-2229, 2004
7. Haw C, Stubbs J: A survey of the off-label use of mood stabilizers in a large psychiatric hospital. Journal of Psychopharmacology 19:402-407, 2005
8. Kessler RC, Berglund P, Demler O, et al: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62:593-602, 2005
9. Beck CA, Williams JVA, Wang JL, et al: Psychotropic medication use in Canada. Canadian Journal of Psychiatry 50:605-613, 2005
10. Guidelines for ATC Classification and DDD assignment. Oslo, World Health Organization Collaborating Centre for Drug Statistics Methodology, 2005
11. Chien IC, Chou YJ, Lin CH, et al: Prevalence of psychiatric disorders among National Health Insurance enrollees in Taiwan. Psychiatric Services 55:691-697, 2004
12. Weiss E, Hummer M, Koller D, et al: Off-label use of antipsychotic drugs. Journal of Clinical Psychopharmacology 20:695-698, 2000
13. Olfson M, Marcus SC, Druss B, et al: National trends in the outpatient treatment of depression. JAMA 287:203-209, 2002
14. Hwu HG, Yeh EK, Chang LY: Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatrica Scandinavica 79:136-147, 1989
15. Huang WF, Lai IC: Patterns of sleep-related medications prescribed to elderly outpatients with insomnia in Taiwan. Drugs and Aging 22:957-965, 2005